Apoptosis
Apoptosis, also known as programmed cell death, is rigorously controlled process of cell death that leads to phagocytosis of unwanted cell. It is triggered after sufficient cellular damage and activated through extrinsic or intrinsic pathways. The intrinsic pathway is mainly occurs via release of cytochrome c from the mitochondria and regulates mitochondrial outer membrane permeabilization by Bcl-2 family proteins. The extrinsic pathway is induced by ligand binding to death receptor, such as Fas, TNFαR, DR3, DR4, and DR5. Caspases then cleave target proteins and nuclear lamins to promote DNA degradation, resulting apoptotic cells undergo phagocytosis. In addition, p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some Inhibitors of apoptosis proteins (IAPs), such as XIAP/BIRC4 and Bruce/BIRC6, can block casapse activity through direct binding, while other IAPs, such as cIAP1/BIRC2, cIAP2/BIRC3, act as ubiquitin ligases that target caspases for ubiquitin-mediated degradation. Apoptosis is essential for growth, development and aging in multicellular organisms. Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases, including cancer.
-
A4450 CHM 1Summary: Tubulin polymerization inhibitor -
A4481 PhiKan 083Target: p53Summary: p53 stabilizer -
A8193 ABT-73731 CitationSummary: BCL-2 protein inhibitor -
A4449 C 75Summary: Fatty acid synthase (FAS) inhibitor -
A4479 MIRA-1Summary: Restorer of wild-type p53 conformation/cellular function -
A8168 HA14-1Target: Bcl-2Summary: Bcl-2 inhibitor,potent and cell-permeable -
A4419 Ac-LEHD-AFCSummary: Fluorogenic caspase substrate -
A4418 Ac-IEPD-AFCSummary: Recognition motif for serine protease granzyme B -
A4448 Actinomycin D52 CitationSummary: RNA polymerase inhibitor -
A4466 Muristerone ASummary: TRAIL- and hFasL-induced apoptosis inhibitor

